Recent studies have shown that tamoxifen, a selective estrogen receptor modulator (SERM), effectively reduced renal tubular injury and fibrosis induced by unilateral ureteral obstruction (UUO) [45,46]. This evidence concerns the gene ESR1 and Ureteral obstruction.